 |
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
 |
||||||||||||||||
|
||||||||||||||||
 |
||||||||||||||||
|
||||||||||||||||
|
|
|
|
Stock data
| Last Trade | 33.92 | Trade Time | 5/20/2013 4:00:00 PM |
| Change |  0.7
|
Volume (thou) | 94.033 |
| %Change | 2.11% | Last Trade Size | |
| Open | 33.24 | Bid | 15 |
| Today's High | 34.5 | Ask | 37.12 |
| Today's Low | 33.24 | Size Bid/Ask | 1 x1 |
Fundamental Data |
|||
| Market Cap (mil) | 570025.6 | 52 Week High | 42.67 |
| Shrs Outstanding (thou) | 16805000 | 52 Week Low | 17.96 |
| EPS | -6.95 | PE Ratio | .00 |
| Volatility | Yield | .00 | |
| Dividend Freq. | 0 | Ex-Dividend Date | 12:00:00 AM |
| Dividend Amount | 0 | Exchange | NASDAQ GM |
| Delayed quotes powered by S&P comstock. All stock quotes are delayed by 20 minutes and are believed to be accurate but are not warranted or guaranteed by MENAFN.com | |||
Related News
 |
Apr 30, 2013 | Intercept Pharmaceuticals Announces Additional Results of Global Primary Biliary Cirrhosis Study Group Analysis Presented at EASL, GlobeNewswire |
|
Apr 25, 2013 | Intercept Pharmaceuticals to Present at Upcoming Healthcare Conferences, GlobeNewswire |
 more... |
||
